Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Biovail grants another license for diltiazem product

Dec. 18, 1996

Beta-blocker treatment reduces fatal post-surgical heart attack

Dec. 18, 1996

Method for treatment of CPVD available for licensing

Dec. 17, 1996

New ET-1 inhibitors from Ciba-Geigy

Dec. 16, 1996

Toray reports peptides for toxic shock syndrome

Dec. 16, 1996

New antihypertensive agents from Banyu

Dec. 16, 1996

Nortran's antiarrhythmic agents receive patent protection

Dec. 13, 1996

Ivax generic cardiovascular drug approved in U.S.

Dec. 13, 1996

New ET antagonist in preclinical testing at Parke-Davis

Dec. 13, 1996

PLC Systems allowed to expand Heart Laser trials

Dec. 13, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...